Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7bce595c861dba361078ba893e4713be |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-0093 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-243 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-00 |
filingDate |
2000-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2002-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2c5c6ae1f5559b0f2a9ced0d9231af9 |
publicationDate |
2002-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-6350740-B1 |
titleOfInvention |
Transplatinum complexes as cytotoxic and anticancer agents |
abstract |
The invention provides a method for enhancing the water solubility of cytotoxic trans-platinum complexes. The present invention also provides a method for killing tumor cells, and a method for the treatment of tumors by the administration of a cytotoxic platinum coordination complex of the general formula SP4-2-[PtX(L)(L′)(B)] + . |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112645871-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017110669-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6806289-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2721725-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2017110669-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112645871-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10946028-B2 |
priorityDate |
2000-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |